Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by davewhoon Dec 01, 2021 9:48am
108 Views
Post# 34184426

RE:RE:Time for some napkin math again...

RE:RE:Time for some napkin math again...the original NR did say Global Growth Strategy. I was also under the impression the GTA move was only for Aristotle. Sounds like you buy Aristotle, a Care Avrt Oncologist calls you to discuss the results then sends a copy to your Dr. Then your Canadian Dr recommends any further action. Since Avrt is run by Care which is US based I doubt people in the GTA would be enter the Care Circle of Care program unless you want to travel to the US for private treatment. The NR was a little short on details of how it would work exactly. Szls obviously wants the US market first and foremost but will take other Countries along the way as they build out. Maybe ask James for the details of how it would work outside the US. 

Collaborations with clinics in the Greater Toronto Area will facilitate specimen collection and are part of StageZero's physical hub-and-spoke model which is being deployed as part of the Company's long-term Global Growth Strategy.


<< Previous
Bullboard Posts
Next >>